cap raise will be done..... and given current MC, I won't be surprised to see it as non diluted....
For an oncology phase 2 company, this is dirt cheap!! strong pre clinical and P1 safety data and strong efficacy on animal models..
again SO will go up and down.... but no point losing sleep over 20-30% drops ..... my tgt is to profit lock on 50% holding at 100m mc... which again is relatively Low and let another 50% ride until just before end of P3 (assuming successful P2)...
cap raise will be done..... and given current MC, I won't...
Add ATX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.7¢ |
Change
-0.003(5.00%) |
Mkt cap ! $11.05M | |||
| Open | High | Low | Value | Volume |
| 6.0¢ | 6.0¢ | 5.7¢ | $16.38K | 275.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 260000 | 5.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.7¢ | 602 | 1 |
View Market Depth
| Last trade - 16.10pm 13/05/2024 (20 minute delay) ? |
|
|||||
|
Last
5.8¢ |
Change
-0.003 ( 2.52 %) |
||||
| Open | High | Low | Volume | ||
| 6.0¢ | 6.0¢ | 5.8¢ | 39070 | ||
| Last updated 15.22pm 13/05/2024 ? | |||||
| ATX (ASX) Chart |